This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
TriMas (TRS) Q1 Earnings Surpass Estimates, Improve Y/Y
by Zacks Equity Research
TriMas' (TRS) 2019 guidance in the range of $1.82 and $1.92, reflects year-over-year growth of 5% at the mid-point.
TriMas (TRS) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
TriMas (TRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
TriMas (TRS) Down 6.5% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
TriMas (TRS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Strong Markets & Products Fuel TriMas Amid High Input Costs
by Zacks Equity Research
Continuous growth across TriMas' (TRS) key markets bodes well for its results.
Strong Markets & Products Fuel TriMas Amid High Input Costs
by Zacks Equity Research
Continuous growth across TriMas' (TRS) key markets bodes well for its results.
Here's Why TriMas (TRS) Stock is Worth Investing in Right Now
by Zacks Equity Research
We suggest investors to retain TriMas (TRS) stock in their portfolio as it is poised to generate stellar returns.
TriMas' (TRS) Q4 Earnings In Line, Sales Beat Estimates
by Zacks Equity Research
For 2019, TriMas (TRS) initiates earnings per share guidance at $1.82-$1.92, backed by organic sales growth of 3-5%.
TriMas (TRS) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
TriMas' (TRS) fourth-quarter results are likely to gain from improving general industrial activity despite higher raw material costs.
TriMas (TRS) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
TriMas (TRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
TriMas Bets on Strong Markets & Products, Input Costs Rise
by Zacks Equity Research
Strong pipeline, cost control initiatives will fuel TriMas (TRS) despite raw material inflation.
TKR vs. TRS: Which Stock Is the Better Value Option?
by Zacks Equity Research
TKR vs. TRS: Which Stock Is the Better Value Option?
Here's Why Investors Should Bet on TriMas (TRS) Stock Now
by Zacks Equity Research
TriMas (TRS) benefits from robust fundamentals and long-term opportunities, which along with other metrics make it an attractive pick.
TKR vs. TRS: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
TKR vs. TRS: Which Stock Is the Better Value Option?
Focus on Cost Cuts & Investments Aids Pentair Amid Inflation
by Zacks Equity Research
Focus on cost reduction and investments is likely to drive Pentair's (PNR) performance in the near term despite material and other cost inflation.
Why Is TriMas (TRS) Down 1.8% Since Last Earnings Report?
by Zacks Equity Research
TriMas (TRS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why TriMas (TRS) Stock Is Worth Investing in Right Now
by Zacks Equity Research
Strong growth prospects, positive estimate revision and upbeat outlook make TriMas(TRS) an attractive investment option.
TriMas Bets on Favorable Markets, New Products & Cost Control
by Zacks Equity Research
Continued momentum in its three segments and focus on improving cost structure will drive growth for TriMas (TRS).
TriMas (TRS) to Acquire Plastic Srl to Boost Rieke Business
by Zacks Equity Research
TriMas' (TRS) acquisition of Plastic Srl will add new products to the Rieke Business of the former.
TKR or TRS: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
TKR vs. TRS: Which Stock Is the Better Value Option?
TriMas (TRS) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
TriMas (TRS) delivered earnings and revenue surprises of 4.35% and 2.18%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
TriMas (TRS) Q3 Earnings Preview: What to Look Out For
by Zacks Equity Research
TriMas (TRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Apogee's Performance to be Marred by View Cut & Inflation
by Zacks Equity Research
Apogee's (APOG) results to be thwarted by lower guidance, concerns in the Architectural Glass segment, margin woes and inflationary.
Worthington Industries (WOR) Misses on Q1 Earnings & Sales
by Zacks Equity Research
Worthington Industries' (WOR) bottom line increases year over year in the first quarter of fiscal 2019 due to rise in net sales.
Timken Boosts Inorganic Growth Trajectory With Rollon Buyout
by Zacks Equity Research
Timken (TKR) acquires Rollon in a bid to fortify existing portfolio of its industrial brands.
Favorable Markets, Focus on New Products to Aid TriMas (TRS)
by Zacks Equity Research
General industrial activity levels have improved, particularly in the United States, and this bodes well for TriMas (TRS).